AA
DGX icon

ALPS Advisors’s Quest Diagnostics DGX Stock Holding History

ALPS Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$805K Buy
3,796
+1,313
+53% +$258K ﹤0.01% 755
2026
Q1 		$487K Sell
2,483
-30
-1% -$5.83K ﹤0.01% 873
2025
Q4 		$436K Buy
2,513
+18
+0.7% +$3.28K ﹤0.01% 838
2025
Q3 		$475K Buy
2,495
+400
+19% +$71K ﹤0.01% 705
2025
Q2 		$376K Buy
2,095
+25
+1% +$4.34K ﹤0.01% 820
2025
Q1 		$350K Buy
+2,070
New +$340K ﹤0.01% 791
2023
Q3 		– Sell
-4,444
Closed -$625K – 1020
2023
Q2 		$625K Sell
4,444
-121
-3% -$16.7K 0.01% 571
2023
Q1 		$646K Sell
4,565
-238
-5% -$34K 0.01% 545
2022
Q4 		$751K Sell
4,803
-273
-5% -$39.2K 0.01% 527
2022
Q3 		$623K Sell
5,076
-12,597
-71% -$1.66M 0.01% 559
2022
Q2 		$2.35M Buy
17,673
+15,206
+616% +$2.07M 0.02% 287
2022
Q1 		$338K Sell
2,467
-1,573
-39% -$219K ﹤0.01% 701
2021
Q4 		$699K Buy
4,040
+1,693
+72% +$258K 0.01% 443
2021
Q3 		$341K Sell
2,347
-417
-15% -$61K ﹤0.01% 781
2021
Q2 		$365K Hold
2,764
– – ﹤0.01% 643
2021
Q1 		$355K Buy
+2,764
New +$341K ﹤0.01% 564
2020
Q3 		– Sell
-2,347
Closed -$267K – 850
2020
Q2 		$267K Sell
2,347
-261
-10% -$27.7K ﹤0.01% 605
2020
Q1 		$209K Sell
2,608
-683
-21% -$70.7K ﹤0.01% 745
2019
Q4 		$351K Sell
3,291
-144
-4% -$15K ﹤0.01% 721
2019
Q3 		$368K Buy
+3,435
New +$353K ﹤0.01% 562
2018
Q4 		– Sell
-11,830
Closed -$1.28M – 891
2018
Q3 		$1.28M Buy
+11,830
New +$1.3M 0.01% 318

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

ALPS Advisors's DGX Position: Q2 2026 in Review

ALPS Advisors increased its Quest Diagnostics (DGX) stake by 53% in Q2 2026, buying an estimated $258K and bringing the position to 3,796 shares worth $805K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

ALPS Advisors first reported a position in DGX in Q3 2018 and has held it in 21 quarters since. The position peaked at $2.35M in Q2 2022. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • ALPS Advisors held 3,796 shares of Quest Diagnostics worth $805K as of Q2 2026.
  • ALPS Advisors bought 1,313 Quest Diagnostics shares in Q2 2026, an estimated $258K.
  • Quest Diagnostics made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #755 holding.
  • ALPS Advisors first reported a position in Quest Diagnostics in Q3 2018 and has held it in 21 quarters since.
  • ALPS Advisors's Quest Diagnostics position peaked at $2.35M in Q2 2022.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.